Keyphrases
Osimertinib
95%
Non-small Cell Lung Cancer (NSCLC)
57%
Multiplexing
47%
Knockdown
47%
Small Molecule Inhibitors
47%
EGFR-mutant NSCLC
47%
Adagrasib
47%
Sotorasib
47%
Plasma Trough Concentration
47%
Brain Metastases
47%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
47%
Metastasis Formation
47%
Thiosulfate Sulfurtransferase
47%
Zebrafish Pronephros
47%
Diabetes
47%
Human Plasma
47%
Population Pharmacokinetic Model
47%
Systematic Evaluation
47%
Dutch
47%
Hyperglycemia
31%
Pancreatic and Duodenal Homeobox 1
31%
Pdx1
31%
Incubation
31%
Thiosulfate
31%
Zebrafish
31%
Cmin
22%
Confidence Interval
19%
Room Temperature
19%
Genetic Predictors
15%
Therapeutic Intervention
15%
INIS
plasma
100%
patients
85%
concentration
76%
lung cells
63%
cancer
63%
adults
57%
humans
47%
brain
47%
metastases
47%
damage
47%
thiosulfates
47%
populations
47%
evaluation
47%
temperature range 0273-0400 k
31%
insulin
28%
pancreas
28%
hyperglycemia
19%
organs
19%
incubation
19%
carbon 18
15%
sarcomas
15%
range
15%
formates
15%
rats
15%
acetonitrile
15%
mutations
15%
precipitation
15%
chromatography
15%
water
15%
decision making
15%
Biochemistry, Genetics and Molecular Biology
Pharmacokinetics
47%
Epidermal Growth Factor Receptor
47%
Minimum Concentration
47%
Trough Concentration
47%
Thiosulfate
47%
Experimental Model
47%
Zebra Fish
47%
Blood Plasma
47%
Homeobox
19%
Hyperglycemia
19%
Goodness of Fit Test
15%
Insulin Release
9%
Nerve Fiber Degeneration
9%
Cell Function
9%
Detoxification Enzyme
9%
Morphology
9%
Insulin Resistance
9%
Cell Survival
9%
Wound Healing Impairment
9%
Rhodanese
9%
Genetics
9%
Minimum Plasma Concentration
6%
Cohort Study
6%
Overall Survival
6%
Metabolite
5%
Clinical Trial
5%
Pharmacokinetic Modeling Software
5%
Blood Level
5%
